Using these data, we propose evidence-derived MIC and disk susceptibility test breakpoints for azithromycin treatment in enteric fever.
Finally, to propose evidence-based policy options to reduce the burden of diabetes, both from an epidemiological as well as an economic perspective, on the Argentinian society.
We propose evidence-based consensus recommendations for the diagnosis of FASD in Australia based on adaption of elements from the UW and Canadian guidelines.
To justify these assumptions, we propose evidence-based effect size estimation: anchoring assumptions in the published literature as much as possible, preferably to results from randomized controlled trials.
Although the primary focus of ESSEA is research, it offers the potential to help build capacity for health systems and clinical care (e.g., raise awareness, spread expertise, provide research to practice solutions, and propose evidence-based clinical guidelines).
The offer contained sixty-two paragraphs of proposed evidence.
In the thirty-five or so years since this theory was proposed, evidence has steadily and diligently been amassed.
While 75 publications describe proposed evidence from > 70 sites, only a limited number provide compelling, well-dated evidence.
As a central feature of our approach, the proposed evidence measures in combination with a statistical mixture model enable an automatic calibration of the prediction threshold.
This novel evidence of RT-mediated intron loss is consistent with previously proposed evidence, such as adjacent intron loss, 3'-biased intron loss and germline-biased expression of IL genes.
